Economic evaluation of toripalimab combined with chemotherapy in the treatment of non-small cell lung cancer

BACKGROUND AND OBJECTIVE: The CHOICE-01 trial showed that toripalimab plus chemotherapy achieved satisfactory outcomes compared with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) who were negative for driver genes, but the economics of this regimen is unclear. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Long, Yunchun, Xu, Yuan, Liao, Li, Zhou, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080092/
https://www.ncbi.nlm.nih.gov/pubmed/37033059
http://dx.doi.org/10.3389/fpubh.2023.1137255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080092/
https://www.ncbi.nlm.nih.gov/pubmed/37033059
http://dx.doi.org/10.3389/fpubh.2023.1137255

Ejemplares similares